Bladder cancer patients get new hope from Virus-Based therapy
NCT ID NCT07505615
First seen Apr 08, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study tested a new treatment called VG161, a virus designed to attack cancer cells, for people with a type of bladder cancer that did not get better with standard therapy. The virus was given directly into the bladder through a tube. The main goals were to see if it is safe, find the best dose, and check if it helps prevent the cancer from coming back. The trial included 20 adults with recurrent bladder cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMIBC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fudan University Shanghai Cancer Center, ShangHai,
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.